(Q24244879)

English

Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease

scientific article

In more languages

edit

Statements

0 references

0 references

1 reference

Europe PubMed Central

title

Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease (English)

0 references

main subject

amyotrophic lateral sclerosis

0 references

author name string

RW Orrell

series ordinal

1

0 references

RJM Lane

series ordinal

2

0 references

M Ross

series ordinal

3

0 references

publication date

24 January 2005

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Role of antioxidants in health maintenance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

ALS, SOD and peroxynitrite

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

21 January 2018

Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic trial in amyotrophic lateral sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cu/Zn superoxide dismutase free radicals, and motoneuron disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Heavy metals and trace elements in amyotrophic lateral sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacology of selegiline ((-)deprenyl). New aspects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002829.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD002829.PUB3

0 references

PubMed publication ID

15674899

0 references

(Q24244879)

Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)